A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19

Zhongchao Wang; Dewei Zhang; Shengming Wang; Yanhua Jin; Jianbo Huan; Yue Wu; Cheng Xia; Zhe Li; Xingshun Qi; Duanzhen Zhang; Xiumin Han; Xianyang Zhu; Ying Qu; Qiguang Wang

doi:10.12659/MSM.926651

24 September 2020 : Clinical Research

A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19

Zhongchao Wang^1ABCDEFG, Dewei Zhang^2BC, Shengming Wang^3BC, Yanhua Jin^2BC, Jianbo Huan^4BC, Yue Wu^5CDF, Cheng Xia^2CD, Zhe Li^6B, Xingshun Qi^7CF, Duanzhen Zhang^1DF, Xiumin Han^1DF, Xianyang Zhu^1DEF, Ying Qu^8ABCDEFG*, Qiguang Wang^9ACDEFG

DOI: 10.12659/MSM.926651

Med Sci Monit 2020; 26:e926651

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Survival analysis before (A) and after (B) propensity score matching of COVID-19 patients complicated with hypertension. ACEIs – angiotensin-converting enzyme inhibitors; ARBs – angiotensin II receptor blockers.

Back to the Article

A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19

Your Privacy